Skip to content

Editors

Harry Cassin
Publisher and Editor

Andy Spalding
Senior Editor

Jessica Tillipman
Senior Editor

Bill Steinman
Senior Editor

Richard L. Cassin
Editor at Large

Elizabeth K. Spahn
Editor Emeritus

Cody Worthington
Contributing Editor

Julie DiMauro
Contributing Editor

Thomas Fox
Contributing Editor

Marc Alain Bohn
Contributing Editor

Bill Waite
Contributing Editor

Shruti J. Shah
Contributing Editor

Russell A. Stamets
Contributing Editor

Richard Bistrong
Contributing Editor

Eric Carlson
Contributing Editor

Search Results for: label/Biomet – Page 3

Who’ll Make The Next Top Ten?

Our list of the ten biggest corporate FCPA cases of all time hasn’t changed since April, when Johnson & Johnson’s $70 million settlement came on as number 10.

Read More »

Medtronic wins double declination

Minnesota-based Medtronic Inc. won a double declination following an FCPA probe that lasted more than five years. The medical device maker said it received word in June from the DOJ and SEC that they won’t pursue enforcement actions.

Read More »

New commentary on FCPA Guide provides valuable insights

The Resource Guide to the U.S. Foreign Corrupt Practices Act was published by the Department of Justice and the U.S. Securities and Exchange Commission in November 2012. The Guide, the merits of which have been widely debated on the FCPA Blog, is now the subject of extensive discussion in the second edition of the Cambridge University Press Commentary on the OECD Convention on Bribery.

Read More »